• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 94

Substance: Docosahexaenoic acid-rich oil from tuna (DHA-rich tuna oil) and arachidonic acid-rich oil from Mortierella alpina (AA-rich fungal oil)
Intended Use: Provide arachidonic acid (AA) at a mean level of 0.4 percent of total fatty acids and docosahexaenoic acid (DHA) at a mean level of 0.25 percent of total fatty acids in preterm infant formula used by hospitalized premature infants; AA at a mean level of 0.4 percent of total fatty acids and DHA at a mean level of 0.15 percent of total fatty acids in preterm infant formula used by post-discharge premature infants; and AA at a mean level of 0.4 percent of total fatty acids and DHA at a mean level of 0.15 percent of total fatty acids in term infant formula
Basis: Scientific procedures
Notifier: Ross Products Division, Abbott Laboratories
625 Cleveland Avenue, Columbus, OH 43215-1724
Date of filing: Jan 2, 2002
GRAS Notice (releasable information): 94 Part 1
94 Part 2
Date of closure / FDA's Letter: Apr 18, 2006
FDA has no questions
-
-